Metraipolis › archive › dc_e4e4640e0b23

Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden? — Europe PMC PMID:42198230

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42198230
DOI
10.3390/pharmaceutics18050536
License (as archived)
solo-consultazione
Archived
2026-11-03T03:24:44.929Z
SHA-256 of the archived text
e4bb8b879a3b7a2e212b7830734e6658d9616d3e8be2933437c5effe9e8eeccd
Stable URL of this page
https://metraipolis.com/documento/dc_e4e4640e0b23

How to cite

Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden? — Europe PMC PMID:42198230 — Europe PMC (en), https://europepmc.org/article/MED/42198230 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e4e4640e0b23 (Metraipolis archive dc_e4e4640e0b23, sha256 e4bb8b879a3b7a2e212b7830734e6658d9616d3e8be2933437c5effe9e8eeccd)
BibTeX
@misc{dce4e4640e0b23,
  title = {Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden? — Europe PMC PMID:42198230},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42198230},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e4e4640e0b23; sha256 e4bb8b879a3b7a2e212b7830734e6658d9616d3e8be2933437c5effe9e8eeccd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198230. Agents can read the archived copy with the MCP tool read_document.